FDA Inspection 1014454 — Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
The FDA completed an inspection of Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. on May 19, 2017 in Zhangjiang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 19, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zhangjiang (China)